Antiepileptic drugs and warfarin
================================

* S. Nizam Ahmed MD

*   © 2008 Canadian Medical Association

In a recent *CMAJ* commentary on drug interactions with warfarin,1 David Juurlink overlooked a very important category of drugs that interact with warfarin: antiepileptic drugs. Phenytoin, carbamazepine and phenobarbital are potent inducers of the cytochrome P450 system, and their interactions with warfarin have been known for decades.2–5 These drugs can substantially increase the rate at which warfarin is metabolized and thus reduce the effect of a previously adjusted dose. Likewise, sudden withdrawal of any of these drugs may decrease the rate at which warfarin is metabolized and put a patient taking a combination of these drugs at an increased risk of bleeding. Antiepileptic drugs are not only prescribed for epilepsy, which is estimated to affect 200 000 Canadians; they are also used to treat psychiatric disorders in a large population of patients. I suggest that Juurlink should add antiepileptic drugs as a ninth category to Table 1.1

## Footnotes

*   **Competing interests:** None declared.

## REFERENCES

1.  1. Juurlink DN. Drug interactions with warfarin: what clinicians need to know. CMAJ 2007;177:369-71.
    
    [FREE Full Text](http://www.cmaj.ca/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiY21haiI7czo1OiJyZXNpZCI7czo5OiIxNzcvNC8zNjkiO3M6NDoiYXRvbSI7czoyMToiL2NtYWovMTc4LzEvNjUuMS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

2.  2. Herman D, Locatelli I, Grabnar I, et al. The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose. Eur J Clin Pharmacol 2006;62:291 -6.
    
    [CrossRef](http://www.cmaj.ca/lookup/external-ref?access_num=10.1007/s00228-006-0104-4&link_type=DOI) 
    
    [PubMed](http://www.cmaj.ca/lookup/external-ref?access_num=16552506&link_type=MED&atom=%2Fcmaj%2F178%2F1%2F65.1.atom) 

3.  3. Solomom GE, Hilgartner MW, Kutt H. Coagulation defects caused by diphenylhydantoin. Neurology 1972;22:1165-71.
    
    [FREE Full Text](http://www.cmaj.ca/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6MzoiUERGIjtzOjExOiJqb3VybmFsQ29kZSI7czo5OiJuZXVyb2xvZ3kiO3M6NToicmVzaWQiO3M6MTA6IjIyLzExLzExNjUiO3M6NDoiYXRvbSI7czoyMToiL2NtYWovMTc4LzEvNjUuMS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

4.  4. Nappi JM. Warfarin and phenytoin interactions. Ann Intern Med 1979;90:852.
    
    [PubMed](http://www.cmaj.ca/lookup/external-ref?access_num=434696&link_type=MED&atom=%2Fcmaj%2F178%2F1%2F65.1.atom) 

5.  5. Udall JA. Clinical implications of warfarin interactions with 5 sedatives. Am J Cardiol 1975;35:67-71.
    
    [CrossRef](http://www.cmaj.ca/lookup/external-ref?access_num=10.1016/0002-9149(75)90560-3&link_type=DOI) 
    
    [PubMed](http://www.cmaj.ca/lookup/external-ref?access_num=1109248&link_type=MED&atom=%2Fcmaj%2F178%2F1%2F65.1.atom) 
    
    [Web of Science](http://www.cmaj.ca/lookup/external-ref?access_num=A1975V272700010&link_type=ISI)